|
|
|
题名
|
作者
|
年代
|
出处
|
被引量
|
| 1 | Safety, tolerability, pharmacokinetics, and pharmacodynamics of single oral doses of BI 1356, an inhibitor of dipeptidyl peptidase 4, in healthy male volunteers显示文摘 | HTTYNER S GRAEFE- MODY EU WITHOPF B et ol | 2008 | J Clin Pharmacol2008，48，10： | 1 |
| 2 | Safety,tolerability,pharmacokinetics,and pharmacodynamics of single oral doses of BI 1356,an inhibitor of dipeptidyl peptidase4,in healthy male volunteers显示文摘 | HUTTNER S GRAEFE-MODY EU WITHOPF B | 2008 | Clin Pharmacol2008，48，10： | 1 |
| 3 | Binding to dipeptidyl peptidase- 4 determines the disposition of linagliptin (BI 1356)-investigations in DPP-4 deficient and wildtype rats 显示文摘 | RETLICH S WITHOPF B GREISCHEL A | 2009 | Biopharm Drug Dispos2009，30，8： | 1 |
| 4 | Safety, tolerability, pharmacokinetics, and pharmacodynamics of single oral doses of BI 1356, an inhibitor of dipeptidyl peptidase 4, in healthy male volunteers显示文摘 | HUTTNER S GRAEFE- MODY EU WITHOPF B | 2008 | J Clin Pharmacol2008，48，10： | 1 |
| 5 | Safety , tolerability, pharmacokinetics , and pharmacodynamics of single oral doses of BI 1356, an inhibitor of dipeptidyl peptidase 4, In healthy male volunteers 显示文摘 | Huttner S Graefe- Mody EU Withopf B et aI | 2008 | J Clin Phannacol2008，48，10： | 1 |
| 6 | Safety, tol- erability, pharmacokinetics, and pharmacodynamics of single oral doses of BI 1356, an inhibitor of Dipeptidyl Peptidase-4, in healthy male volunteers 显示文摘 | Huttner S Graefe-Mody EU Withopf B | 2008 | J Clin Phar- macol2008，48，10： | 1 |
您所在的机构暂未开通此部分的功能，请联系管理员